[1] XUE Z,WU C,WEI J,et al.An orally administered magnoloside a ameliorates functional dyspepsia by modulating brain-gut peptides and gut-microbiota[J].Life Sci,2019,233(15):116749.
[2] DROSSMAN D A.Functional gastrointestinal disorders:history,pathophysiology,clinical features and Rome Ⅳ[J].Gastroenterology,2016,150(6):1262-1279.
[3] WAUTERS L,TALLEY N J,WALKER M M,et al.Novel concepts in the pathophysiology and treatment of functional dyspepsia[J].Gut,2020,69(3):591-600.
[4] MALAGELADA J R.The Brain-Gut Team[J].Dig Dis,2020,38(4):293-298.
[5] STANGHELLINI V,TOSETTI C,PATERNICO A,et al.Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia[J].Gastroenterology,1996,110(4):1036-1042.
[6] TACK J,PIESSEVAUX H,COULIE B,et al.Role of impaired gastric accommodation to a meal in functional dyspepsia[J].Gastroenterology,1998,115(6):1346-1352.
[7] STANGHELLINI V,TOSETTI C,HOROWITZ M,et al.Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptoms[J].Dig Liver Dis,2003,35(6):389-396.
[8] HIROKAZU F,XIN X.Role of gut microbiota-gut hormone axis in the pathophysiology of functional gastrointestinal disorders[J].J Neurogastroenterol Motil,2018,24(3):367-386.
[9] YAGI T,ASAKAWA A,UEDA H,et al.The role of ghrelin in patients with functional dyspepsia and its potential clinical relevance (Review)[J].Int J Mol Med,2013,32(3):523-531.
[10] MURRAY C D,MARTIN N M,PATTERSON M,et al.Ghrelin enhances gastric emptying in diabetic gastroparesis:a double blind,placebo controlled,crossover study[J].Gut,2005,54(12):1693-1698.
[11] SHINOMIYA T,FUKUNAGA M,AKAMIZU T,et al.Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients[J].Scand J Gastroenterol,2005,40(6):648-653.
[12] CHEUNG C K,LEE Y Y,CHAN Y,et al.Decreased Basal and postprandialplasma serotonin levels in patients with functional dyspepsia[J].Clin Gastroenterol Hepatol.2013,11(9):1125-1129.
[13] JIN M,MO Y,YE K,et al.Efficacy of serotonin receptor agonists in thetreatment of functional dyspepsia:a meta-analysis[J].Arch Med Sci,2019,15(1):23-32.
[14] LUNDING J A,NORDSTRÖM L M,HAUKELID A O,et al.Vagal activation by sham feeding improves gastric motility in functional dyspepsia[J].Neurogastroenterol Motil,2008,20(6):618-624.
[15] FRØKJAER J B,BERGMANN S,BROCK C,et al.Modulation of vagal tone enhances gastroduodenal motility and reduces somatic pain sensitivity[J].Neurogastroenterol Motil,2016,28(4):592-598.
[16] GUO W J,YAO S K,ZHANG Y L,et al.Impaired vagal activity to meal in patients with functional dyspepsia and delayed gastric emptying[J].J Int MedRes,2018,46(2):792-801.
[17] TACK J,CAENEPEEL P,FISCHLER B,et al.Symtoms associated with hypersensitivity to gastric distention in functional dyspepsia[J].Gastroenterology,2001,121(3):526-535.
[18] MEARIN F,CUCALA M,AZPIROZ F,et al.The origin of symptoms on the brain-gut axis in functional dyspepsia[J].Gastroenterology,1991,101(4):999-1006.
[19] TAKI M,OSHIMA T,LI M,et al.Duodenal low-grade inflammation and expression of tight junction proteins in functional dyspepsia[J].Neurogastroenterol Motil,2019,31(10):e13576.
[20] DU L,CHEN B,KIM J J,et al.Micro-Inflammation in functional dyspepsia:a systematic review and meta-analysis[J].Neurogastroenterol Motil,2018,30(4):e13304.
[21] BURNS G,CARROLL G,MATHE A,et al.Evidencefor local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome:a systematic review[J].Am J Gastroenterol,2019,114(3):429-436.
[22] WIKOFF W R,ANFORA A T,LIU J,et al.Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites[J].Proc Natl Acad Sci,2009,106(10):3698-3703.
[23] 刘鹏程,林上助,祝梅君.根除幽门螺旋杆菌对功能性消化不良的影响[J].临床医学,2008,28(6):5-6.
[24] 陈吉,白晓茹,王忠,等.功能性消化不良与幽门螺杆菌感染的关系研究[J].胃肠病学和肝病学杂志,2001,10(4):364-365.
[25] LIN S,GAO T,SUN C,et al.The association between functional dyspepsia and depression:a meta-analysis of observational studies[J].Eur J Gastroenterol Hepatol,2019,31(8):911-918.
[26] ARO P,TALLEY N J,RONKAINEN J,et al.Anxiety is associated with univestigated and functional Dyspepsia (Rome Ⅲ criteria) in a Swedish population-based study[J].Gastroenterology,2009,137(1):94-100.
[27] DIBAISE J K,ISLAM R S,DUECK A C,et al.Psychological distress in Rome III functional dyspepsia patients presenting for testing of gastric emptying[J].Neurogastroenterol Motil,2016,28(2):196-205.
[28] JIANG S M,JIA L,LEI X G,et al.Incidence and psychological behavioral characteristics of refractory functional dyspepsia:a large,multi-center,prospective investigation from China[J].World J Gastroenterol,2015,21(6):1932-1937.
[29] LABANSKI A,LANGHORST J,ENGLER H,et al.Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases:a transdisciplinary challenge[J].Psychoneuroendocrinology,2020,111(10):104501.
[30] MOAYYEDI P,LACY B E,ANDREWS C N,et al.ACG and CAG clinical guideline:management of dyspepsia[J].Am J Gastroenterol,2017,112(7):988-1013.
[31] PINTO-SANCHEZ M I,YUAN Y,BERCIK P,et al.Proton pump inhibitors for functional dyspepsia[J].Cochrane Database Syst Rev,2017,3(3):CD011194.
[32] POTTER M D E,GOODSALL T M,WALKER M M,et al.Dual histamine blockade for the treatment of adult functional dyspepsia:a single centre experience[J].Gut,2020,69(5):966.
[33] HIYAMA T,YOSHIHARA M,MATSUO K,et al.Meta-analysis of the effects ofprokinetic agents in patients with functional dyspepsia[J].J Gastroenterol Hepatol,2007,22(3):304-310.
[34] HIYAMA T,YOSHIHARA M,MATSUO K,et al.Treatment of Functional dyspepsia with serotonin agonists:a meta-analysis of randomized controlled trials[J].J Gastroenterol Hepatol,2007,22(10):1566-1570.
[35] ENCK P,AZPIROZ F,BOECKXSTAENS G,et al.Functional dyspepsia[J].Nat Rev Dis Primers,2017,3(3):17081.
[36] TACK J,CAMILLERI M.New developments in the treatment of gastroparesisand functional dyspepsia[J].Curr Opin Pharmacol,2018,43:111-117.
[37] QUIGLEY E M.Cisapride:what can we learn from the rise and fall of a proknetic?[J].J Dig Dis,2011,12(3):147-156.
[38] BLACK C J,HOUGHTON L A,FORD A C.Insights into the evaluation and management of dyspepsia:recent developments and new guidelines[J].Therap Adv Gastroenterol,2018,11:1756284818805597.
[39] TÖRNBLOM H,DROSSMAN D A.Psychotropics,antidepressants,and visceral analgesics in functional gastrointestinal disorders[J].Curr Gastroenterol Rep,2018,20(12):58.
[40] TALLEY N J,LOCKE G R,SAITO Y A,et al.Effect of amitriptyline and escitalopram on functional dyspepsia:a multi-center,randomized,controlled study[J].Gastroenterology,2015,149(2):340-349.
[41] FORD A C,LUTHRA P,TACK J,et al.Efficacy of psychotropic drugs in functional dyspepsia:systematic review and meta-analysis[J].Gut,2017,66(3):411-420.
[42] LUO L,DU L,SHEN J,et al.Benefit of small dose antidepressants for functional dyspepsia:Experience from a tertiary center in eastern China[J].Medicine (Baltimore),2019,98(41):e17501.
[43] 李军祥,陈誩,李岩.功能性消化不良中西医结合诊疗共识意见[J].中国中西医结合消化杂志,2017,25(12):889-894.
[44] 张声生,赵鲁卿.功能性消化不良中医诊疗专家共识意见[J].中华中医药杂志,2017,32(6):2595-2598.
[45] VANHEEL H,VICARIO M,BOESMANS W,et al.Activation of eosinophils and mast cells in functional dyspepsia:an ultrastructural evaluation[J].Sci Rep,2018,8(1):5383.
[46] TAKI M,OSHIMA T,LI M,et al.Duodenal low-grade inflammation and expression of tight junction proteins in functional dyspepsia[J].Neurogastroenterol Motil,2019,31(10):e13576. |
